Pharmacy News

Dr Marie Sartain
/ Categories: APhA News

FDA panel considers OTC birth control

FDA advisers are slated to meet in early May to discuss whether the agency should approve an OTC oral contraceptive.

If approved, HRA Pharma’s Opill would be the first-ever daily birth control available OTC in the United States. Opill has been available with a prescription since its approval 50 years ago.

HRA Pharma submitted an application to switch from prescription to OTC status last July, and in October a previously scheduled FDA meeting was pushed back to review additional data requested by the company.

Previous Article Telehealth services during pandemic seemed to reduce fatal overdose risk
Next Article CDC: ADHD drugs for adults spiked during pandemic
8186 Rate this article:
No rating
Please login or register to post comments.